Gilead Sciences, Inc. (FRA:GIS)
102.52
-0.36 (-0.35%)
At close: Aug 13, 2025
Gilead Sciences Revenue
Gilead Sciences had revenue of $7.08B USD in the quarter ending June 30, 2025, with 1.84% growth. This brings the company's revenue in the last twelve months to $28.86B, up 3.81% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75B with 6.04% growth.
Revenue (ttm)
$28.86B
Revenue Growth
+3.81%
P/S Ratio
5.18
Revenue / Employee
$1.64M
Employees
17,600
Market Cap
127.25B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.75B | 1.64B | 6.04% |
Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
Dec 31, 2021 | 27.31B | 2.62B | 10.60% |
Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Rheinmetall AG | 10.67B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Gilead Sciences News
- 3 days ago - Gilead Sciences (GILD) Boosts Full-Year Outlook Amid Strong HIV Demand - GuruFocus
- 5 days ago - Gilead Sciences shares soar; analysts lift targets on HIV strength and Yeztugo outlook - Invezz
- 5 days ago - NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Gains Ground As Gilead Sciences Soars 8% - FX Empire
- 5 days ago - S&P500 and Nasdaq 100: Bulls Eye Weekly Gains as Tech Stocks Drive US Indices - FX Empire
- 5 days ago - Stocks making the biggest moves midday: Gilead Sciences, Monster Beverage, Trade Desk, MP Materials, Sweetgreen and more - CNBC
- 5 days ago - Gilead Sciences jumps after Q2 beat; Truist upgrades to Buy - Seeking Alpha
- 6 days ago - Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears - Benzinga
- 6 days ago - Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears - Benzinga